Skip to Content
Merck
CN

D031

Supelco

N,N-Dipropyldopamine hydrobromide

solid

Sign Into View Organizational & Contract Pricing

Select a Size

About This Item

Empirical Formula (Hill Notation):
C14H23NO2 · HBr
CAS Number:
65273-66-7
Molecular Weight:
318.25
MDL number:
MFCD00069242
UNSPSC Code:
41116107

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

form

solid

technique(s)

HPLC: suitable
gas chromatography (GC): suitable

color

white

solubility

aqueous base: unstable
ethanol: soluble (Solutions should be freshly prepared and kept at 4 °C.)
oxygen-free water containing 0.1% sodium metabisulfite or other antioxidant: soluble (Solutions should be freshly prepared and kept at 4 °C.)

application(s)

forensics and toxicology
veterinary

storage temp.

2-8°C

SMILES string

Br.CCCN(CCC)CCc1ccc(O)c(O)c1

Gene Information

human ... DRD1(1812), DRD2(1813), DRD3(1814), DRD4(1815), DRD5(1816)

Biochem/physiol Actions

Dopamine receptor agonist.

Packaging

Packaged under argon.

Disclaimer

Photosensitive

Storage Class Code

13 - Non Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

A Hilditch et al.
Journal of cardiovascular pharmacology, 6(3), 460-469 (1984-05-01)
The interactions between several putative dopamine receptor agonists and antagonists have been examined at neuronal and vascular dopamine receptors in the femoral and mesenteric vascular beds, respectively, of anaesthetised dogs. N,N-di-n- propyldopamine (DPDA) and apomorphine caused vasodilatation in both vascular
R A Hahn et al.
The Journal of pharmacology and experimental therapeutics, 229(1), 132-138 (1984-04-01)
Administration of N,N-di-n-propyldopamine (DPDA) (1-100 micrograms/kg i.v.) and LY171555 (1-100 micrograms/kg i.v.) produced dose-related arterial hypotension accompanied by bradycardia in anesthetized rhesus monkey. The cardiovascular effects of DPDA were of brief duration, whereas hypotension and bradycardia induced by LY171555 were
I Cavero et al.
Life sciences, 31(11), 1059-1069 (1982-09-13)
Relatively selective dopamine receptor agonists, like bromocriptine, lergotrile, pergolide and N,N-di-n-propyl-dopamine, lower arterial pressure in conscious spontaneously hypertensive rats and in several anesthetized animal preparations. This effect has been attributed to stimulation of dopamine receptors since it can be specifically

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service